DOSEGUY

Piracetam

weak data

Also seen as: Nootropil, UCB 6215, Lucetam, pira

The Dose Guy’s verdict
Sep 1, 2026
3 sources

Piracetam has more human data than almost anything else on this shelf, and the answer is still underwhelming. It works in clinical niches, pediatric breath-holding spells especially, but the dream that piracetam sharpens a healthy brain has never been tested in a controlled trial. It is cheap, safe, and easy to try. Just calibrate your expectations.

Would I take it?The grandfather, still unproven.

What it is

The first racetam, synthesized in 1964, and the compound that gave the world the word “nootropic.” Piracetam modulates AMPA receptors and improves neuronal membrane fluidity, helping damaged or aging neurons communicate better without the obvious kick of a stimulant. It has been prescribed across Europe and Russia for decades for cognitive decline, vertigo, and various neurological conditions. In the community it is the entry point: cheap, subtle, and endlessly debated.

Among the racetams, piracetam is the gentlest and the weakest by dose. Pramiracetam runs at a fraction of the dose for deeper focus. Aniracetam adds an anxiolytic color. Phenylpiracetam adds stimulant energy. They all trace back here.

What the research shows

The evidence is voluminous and underwhelming for healthy cognition. It tells a clear story: piracetam does something, just not reliably what the nootropic buyer is hoping for.

Meta-analysis of 18 studies and 886 adults with memory impairment found no significant benefit versus placebo, SMD 0.75 with 95% CI -0.19 to 1.69, p=0.12. Heterogeneity was extreme at I²=96%.Clin Neurol Neurosurg 2024 · meta-analysis · n=886
In post-stroke aphasia, no significant improvement in overall severity, SMD 0.23, p=0.08. Written language alone showed a signal at SMD 0.35, p=0.03.CNS Drugs 2016 · meta-analysis · 7 RCTs · n=261
In pediatric breath-holding spells, piracetam beat placebo decisively: favorable response at 3 months RR 5.4, 95% CI 3.4 to 8.5, p<0.0001. Complete cessation RR 5.7, p=0.01.Eur J Pediatr 2024 · meta-analysis · 5 RCTs · n=437
No controlled trial of piracetam for cognitive enhancement in healthy adults exists in the indexed literature.as of Aug 2026

Realistic protocols

Most people start at 800 mg two or three times a day, looking for a subtle lift in verbal fluidity or recall, the typical piracetam signal. If a lower dose is working, stay there. The full community dose is 4800 mg a day, split into three doses, but more is not automatically better. If nothing registers at that level, piracetam is probably not your racetam, and going higher will not change that.

Pair it with a choline source. Piracetam increases acetylcholine turnover, and the headache every first-timer hears about goes away when you add choline. Alpha-GPC or CDP-choline with each dose handles it. Take piracetam with or without food.

Start800–1600 mg 2–3x/dayYou are looking for a subtle shift, not a high. Hold here if it works.
Full dose1600 mg 3x/day4800 mg/day. Only if the lower range is not landing.
The stack+ choline sourceAlpha-GPC or CDP-choline. Prevents the piracetam headache.

Side effects

Piracetam is one of the safest compounds on the shelf. The issues are minor:

anecdotalHeadaches, the most-reported community side effect. Adding a choline source resolves them for most people.
anecdotalInsomnia if dosed late in the day, per community reports. The 200-patient vertigo trial actually found drowsiness as the most common side effect.
anecdotalMild GI irritation at higher doses. Taking it with food helps.
unknownThe trials are extensive but mostly short-term and in impaired populations. No long-term safety study in healthy people taking piracetam for cognitive enhancement exists.

Where to buy

PCT.zone–
$4.95 / 800mg vial$0.006/mg
✓ verified Sep 12
Read review →
Visit →

Prices move. Links are affiliate links; they never change a ranking, and scores are set before the deal exists.